Over the last decade, severe bacterial infections associated with intravenous drug use have been increasing in frequency in the U.S. Many studies examine the injection risk behaviors associated with transmission of HIV and ...
May 19, 2022
0
5
Nearly a third of pregnant Medicaid beneficiaries who have opioid use disorder and are screened for hepatitis C test positive for the potentially deadly, liver-destroying virus, according to new findings made by a research ...
May 17, 2022
0
4
Instead of relying on the cell's repair mechanisms, the vaccinia virus MacGyvers a tool for DNA repair from one that it already uses to copy DNA, reports a team of researchers at the Medical University of South Carolina (MUSC) ...
May 17, 2022
0
96
Developing new drugs that remain potent against emerging variants of COVID-19 is essential to stopping the spread of the highly contagious disease and protecting human health.
May 2, 2022
0
41
Nearly a third of pregnant Medicaid beneficiaries who have opioid use disorder and are screened for hepatitis C test positive for the potentially deadly, liver-destroying virus, according to new findings made by a research ...
Apr 7, 2022
0
7
Traditional eligibility criteria differentially exclude Black patients from participating in clinical trials for pancreatic ductal adenocarcinoma (PDAC), according to a study published online March 22 in the Journal of Clinical ...
Apr 7, 2022
0
3
Medicare Part D beneficiaries who did not receive federal subsidies to lower their out-of-pocket costs were nearly twice as likely as others to not fill prescriptions for serious health conditions like cancer or hepatitis ...
Apr 4, 2022
0
33
A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care ...
Mar 24, 2022
0
0
Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized ...
Feb 18, 2022
0
11
